SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-015208
Filing Date
2022-03-25
Accepted
2022-03-25 17:00:33
Documents
58
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_actiniumpharma.htm   iXBRL 10-K 1184903
2 CONSENT OF MARCUM LLP f10k2021ex23-1_actinium.htm EX-23.1 2129
3 CERTIFICATION f10k2021ex31-1_actinium.htm EX-31.1 8570
4 CERTIFICATION f10k2021ex31-2_actinium.htm EX-31.2 8804
5 CERTIFICATION f10k2021ex32-1_actinium.htm EX-32.1 3794
6 CERTIFICATION f10k2021ex32-2_actinium.htm EX-32.2 3766
  Complete submission text file 0001213900-22-015208.txt   4499003

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnm-20211231.xsd EX-101.SCH 43286
8 XBRL CALCULATION FILE atnm-20211231_cal.xml EX-101.CAL 27070
9 XBRL DEFINITION FILE atnm-20211231_def.xml EX-101.DEF 198992
10 XBRL LABEL FILE atnm-20211231_lab.xml EX-101.LAB 412616
11 XBRL PRESENTATION FILE atnm-20211231_pre.xml EX-101.PRE 212275
52 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_actiniumpharma_htm.xml XML 391363
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36374 | Film No.: 22772177
SIC: 2834 Pharmaceutical Preparations